AIM IMMUNOTECH (Germany) Probability of Future Stock Price Finishing Over 2.12

HXB2 Stock  EUR 0.40  0.05  11.11%   
AIM IMMUNOTECH's future price is the expected price of AIM IMMUNOTECH instrument. It is based on its current growth rate as well as the projected cash flow expected by the investors. This tool provides a mechanism to make assumptions about the upside potential and downside risk of AIM IMMUNOTECH INC performance during a given time horizon utilizing its historical volatility. Check out AIM IMMUNOTECH Backtesting, AIM IMMUNOTECH Valuation, AIM IMMUNOTECH Correlation, AIM IMMUNOTECH Hype Analysis, AIM IMMUNOTECH Volatility, AIM IMMUNOTECH History as well as AIM IMMUNOTECH Performance.
For more detail on how to invest in AIM Stock please use our How to Invest in AIM IMMUNOTECH guide.
  
Please specify AIM IMMUNOTECH's target price for which you would like AIM IMMUNOTECH odds to be computed.

AIM IMMUNOTECH Target Price Odds to finish over 2.12

The tendency of AIM Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move over € 2.12  or more in 90 days
 0.40 90 days 2.12 
close to zero percent
Based on a normal probability distribution, the odds of AIM IMMUNOTECH to move over € 2.12  or more in 90 days from now is close to zero percent (This AIM IMMUNOTECH INC probability density function shows the probability of AIM Stock to fall within a particular range of prices over 90 days) . Probability of AIM IMMUNOTECH INC price to stay between its current price of € 0.40  and € 2.12  at the end of the 90-day period is about 23.51 .
Assuming the 90 days trading horizon the stock has the beta coefficient of 1.27 . This usually indicates as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, AIM IMMUNOTECH will likely underperform. Additionally AIM IMMUNOTECH INC has an alpha of 0.4908, implying that it can generate a 0.49 percent excess return over NYSE Composite after adjusting for the inherited market risk (beta).
   AIM IMMUNOTECH Price Density   
       Price  

Predictive Modules for AIM IMMUNOTECH

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as AIM IMMUNOTECH INC. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of AIM IMMUNOTECH's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.4010.12
Details
Intrinsic
Valuation
LowRealHigh
0.020.3310.05
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as AIM IMMUNOTECH. Your research has to be compared to or analyzed against AIM IMMUNOTECH's peers to derive any actionable benefits. When done correctly, AIM IMMUNOTECH's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in AIM IMMUNOTECH INC.

AIM IMMUNOTECH Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. AIM IMMUNOTECH is not an exception. The market had few large corrections towards the AIM IMMUNOTECH's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold AIM IMMUNOTECH INC, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of AIM IMMUNOTECH within the framework of very fundamental risk indicators.
α
Alpha over NYSE Composite
0.49
β
Beta against NYSE Composite1.27
σ
Overall volatility
0.06
Ir
Information ratio 0.05

AIM IMMUNOTECH Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of AIM IMMUNOTECH for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for AIM IMMUNOTECH INC can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
AIM IMMUNOTECH INC is way too risky over 90 days horizon
AIM IMMUNOTECH INC has some characteristics of a very speculative penny stock
AIM IMMUNOTECH INC appears to be risky and price may revert if volatility continues
The company reported the revenue of 135 K. Net Loss for the year was (16.7 M) with loss before overhead, payroll, taxes, and interest of (715 K).
AIM IMMUNOTECH INC has accumulated about 41.14 M in cash with (10.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

AIM IMMUNOTECH Technical Analysis

AIM IMMUNOTECH's future price can be derived by breaking down and analyzing its technical indicators over time. AIM Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of AIM IMMUNOTECH INC. In general, you should focus on analyzing AIM Stock price patterns and their correlations with different microeconomic environments and drivers.

AIM IMMUNOTECH Predictive Forecast Models

AIM IMMUNOTECH's time-series forecasting models is one of many AIM IMMUNOTECH's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary AIM IMMUNOTECH's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

Things to note about AIM IMMUNOTECH INC

Checking the ongoing alerts about AIM IMMUNOTECH for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for AIM IMMUNOTECH INC help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
AIM IMMUNOTECH INC is way too risky over 90 days horizon
AIM IMMUNOTECH INC has some characteristics of a very speculative penny stock
AIM IMMUNOTECH INC appears to be risky and price may revert if volatility continues
The company reported the revenue of 135 K. Net Loss for the year was (16.7 M) with loss before overhead, payroll, taxes, and interest of (715 K).
AIM IMMUNOTECH INC has accumulated about 41.14 M in cash with (10.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.86, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check out AIM IMMUNOTECH Backtesting, AIM IMMUNOTECH Valuation, AIM IMMUNOTECH Correlation, AIM IMMUNOTECH Hype Analysis, AIM IMMUNOTECH Volatility, AIM IMMUNOTECH History as well as AIM IMMUNOTECH Performance.
For more detail on how to invest in AIM Stock please use our How to Invest in AIM IMMUNOTECH guide.
Note that the AIM IMMUNOTECH INC information on this page should be used as a complementary analysis to other AIM IMMUNOTECH's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Complementary Tools for AIM Stock analysis

When running AIM IMMUNOTECH's price analysis, check to measure AIM IMMUNOTECH's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy AIM IMMUNOTECH is operating at the current time. Most of AIM IMMUNOTECH's value examination focuses on studying past and present price action to predict the probability of AIM IMMUNOTECH's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move AIM IMMUNOTECH's price. Additionally, you may evaluate how the addition of AIM IMMUNOTECH to your portfolios can decrease your overall portfolio volatility.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Please note, there is a significant difference between AIM IMMUNOTECH's value and its price as these two are different measures arrived at by different means. Investors typically determine if AIM IMMUNOTECH is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AIM IMMUNOTECH's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.